Skip to main content
See every side of every news story
Published loading...Updated

Generic weight-loss drug approval ‘really good news,’ but doctor warns of long-term consequences

Summary by CTV News
Health Canada’s approval of the generic version of semaglutide, commonly known as Ozempic, has been heralded as a sea change in improving accessibility to a life-changing drug.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CTV News broke the news in Canada on Thursday, April 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal